NCT06131489View on ClinicalTrials.gov

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

January 1, 2027

Conditions
Hemophagocytic LymphohistiocytosisEpstein-Barr VirusBowel Resection
Interventions
OTHER

Segmental bowel resection combined with the DEP regimen

Segmental bowel resection combined with liposomal doxorubicin, etoposide, and methylprednisolone administered in 2 week cycles for 2 cycles

Trial Locations (1)

100050

Zhao Wang, Beijing

All Listed Sponsors
lead

Beijing Friendship Hospital

OTHER

NCT06131489 - Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement | Biotech Hunter | Biotech Hunter